Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
193
datasets available to search
ShareScore release 0.9.0
Dataset results
193 results for “CD20”
Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00742144. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors
ClinicalTrials.gov study NCT06503094. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody
ClinicalTrials.gov study NCT05045664. IPD Sharing: NO. Countries: 1. Publications: 4.
Efficacy of Anti-CD20 Ab Associated With Anti-CD38 in the Childhood Multidrug Dependent and Resistant Nephrotic Syndrome
ClinicalTrials.gov study NCT05704400. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of Dulanermin in Combination With Rituximab in Subjects With Follicular and Other Low Grade, CD20+, Non-Hodgkin's Lymphomas
ClinicalTrials.gov study NCT00400764. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), Rituximab
ClinicalTrials.gov study NCT00379431. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic Anemia
ClinicalTrials.gov study NCT04083014. IPD Sharing: YES. Countries: 1. Publications: 13.
HuMax-CD20 in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Failing Fludarabine and Alemtuzumab
ClinicalTrials.gov study NCT00349349. IPD Sharing: Not stated. Countries: 0. Publications: 3.
Risk Stratified Sequential Treatment for CD20-positive PTLD
ClinicalTrials.gov study NCT00590447. IPD Sharing: Not stated. Countries: 7. Publications: 1.
FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies
ClinicalTrials.gov study NCT04245722. IPD Sharing: NO. Countries: 1. Publications: 2.
Study of HuMax-CD20, a New Drug to Treat Early Stage Non-Hodgkin´s Follicular Lymphoma
ClinicalTrials.gov study NCT00092274. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Sequential Infusion of Anti-CD19 and Anti-CD20 CAR-T Cells Against Relapsed and Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT03207178. IPD Sharing: NO. Countries: 1. Publications: 6.
Clinical Study to Compare the Efficacy and Safety of Rituximab Biosimilar HLX01 and Rituximab in Combination With CHOP, in Previously Untreated Subjects With CD20+ DLBCL
ClinicalTrials.gov study NCT02787239. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of Anti CD20 in Pemphigus Desease
ClinicalTrials.gov study NCT00213512. IPD Sharing: Not stated. Countries: 1. Publications: 1.
HuMax-CD20 in Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00093314. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00354926. IPD Sharing: Not stated. Countries: 1. Publications: 1.
B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Very Severe Chronic Fatigue Syndrome
ClinicalTrials.gov study NCT01156922. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Anti-CD20 Antibody Therapy for Sjogren's Syndrome
ClinicalTrials.gov study NCT00101829. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Acalabrutinib in Combination With Anti-CD20 and Venetoclax in Relapsed/Refractory or Untreated CLL/SLL/PLL
ClinicalTrials.gov study NCT02296918. IPD Sharing: YES. Countries: 1. Publications: 2.
Ibrutinib, Bortezomib and Rituximab-CHOP for the Treatment of Elderly Patients With CD20+ DLBCL, IPI ≥ 2
ClinicalTrials.gov study NCT03129828. IPD Sharing: NO. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.